Holdings of Sanofi
8 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 100 % of the equity sleeve
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 87.3 %
- BE 12.7 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 7 | 201.1M $ | 87.32 % |
| 2 | BE | 1 | 29.2M $ | 12.68 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Inhibrx Biosciences Inc | 1,157,926 | 77.8M $ | |
| 2 | Novavax Inc | 6,880,481 | 56M $ | |
| 3 | AnaptysBio Inc | 821,917 | 30.4M $ | |
| 4 | AGOMAB THERAPEUTICS SA | 2,783,096 | 29.2M $ | |
| 5 | MapLight Therapeutics Inc | 912,041 | 18.5M $ | |
| 6 | Immuneering Corp | 2,708,559 | 14.3M $ | |
| 7 | Eledon Pharmaceuticals Inc | 814,980 | 2.5M $ | |
| 8 | Q32 Bio Inc | 244,083 | 1.6M $ |